Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy

The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized,…

• S
  Sanofi
• V
  Vitaflo
• JP
  Jazz Pharmaceuticals
• L
  LifeArc
• Z
  Zogenix
• I
  Innovationsfonden
• UP
  Ultragenyx Pharmaceutical
• L
  LivaNova
• GP
  GW Pharmaceuticals
• ST
  Sage Therapeutics
• SL
  SK Life Science
• NI
  National Institute for Health and Care Research
• UO
  University of Cambridge
• UO
  University of Oxford
• EC
  European Commission

  Awards: 11.10.2022, PE0000006
• GO
  Great Ormond Street Hospital Charity
• MD
  Ministero della Salute
• E
  Eisai
• AP
  Angelini Pharma
• OP
  Otsuka Pharmaceutical
• OP
  Ono Pharmaceutical
• HL
  H. Lundbeck A/S
• N
  Neuraxpharm
• G
  Genentech
• HE
  HORIZON EUROPE Framework Programme
• EA
  Engineering and Physical Sciences Research Council
• GO
  Great Ormond Street Institute of Child Health
• NI
  National Institute of Neurological Disorders and Stroke
• UP
  UCB Pharma
• E
  Eurostars